Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaiyuan Hengtai Nutrition is a China-based manufacturer of nutritional ingredients and specialty chemical products focused on development, production, and sales of nutrition supplements. The company’s core commercial products include L-carnitine series products, ascorbyl palmitate, gamma-aminobutyric acid, and phenibut, which are sold into food, health product, and feed markets. It appears to operate primarily as an ingredient supplier rather than a drug developer, with manufacturing, quality systems, and export capabilities emphasized more than therapeutic R&D. The business has described itself as a high-tech enterprise with a provincial technology center and multiple quality certifications, and it has exported products to Europe, the United States, and other international markets. Based on available information, it is best characterized as a commercial nutrition and fine-chemical manufacturer relevant to healthcare supply chains, not a clinical-stage biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaiyuan Hengtai Nutrition.